Teva Highlights New Real-World Data Showing UZEDY® (risperidone) Outperforms Other Long-Acting Injectables in Keeping Schizophrenia Patients on Treatment, While Reducing Emergency Care and Healthcare Costsfinancialpost.com18h agoRead at financialpost.comEarlier from this sourceMISSION SUCCESS: Rocket Lab Launches 96th Electron Mission10h agoCollective Metals Announces Management Changes14h agoLiberty Gold Files Feasibility Study Technical Report for the Black Pine Project in Idaho, USA15h agoAjax library workers reject two-tier contract: ‘We need a fair deal for everyone’15h agoGreenland Mines Applauds Historic U.S.-Denmark-Greenland Security Agreement, Reinforcing Greenland’s Strategic Importance to the United States15h agoOttawa’s ‘mega deduction’ tax write-off could boost these TSX stocks, analysts say16h agoNews of the day: The antagonist next door, variable-rate’s moment, how high will interest rates go, workplace investigations, dual-citizen taxes and more17h agoPIMCO Canada Corp. Announces Monthly Distributions for PIMCO Canada Closed End Funds17h agoHow this page changedShareSign in to saveLink